Identifying and Managing Renal Complications in Patients with T2D and CVD

People with T2D and CKD are at three times higher risk of dying from a cardiovascular event. According to the National Kidney Foundation, the two main causes of CKD are diabetes and high blood pressure. These two conditions were the primary diagnosis in 75% of kidney failure cases between 2015–2017.

Listen to Dr. George Bakris, Nephrologist, with expertise in diabetes-related kidney disease, and Dr. Peter McCullough, Cardiologist, who is also board certified in internal medicine, discuss how to better screen and manage patients with T2D who are at risk for CVD and renal disease.

Play the podcast in Apple Podcasts.

podcast player graphic

2020 Episode 5 – Identifying and Managing Renal Complications in Patients with T2D and CVD

Download the 2020 Episode 5 Transcript.

Peter A. McCullough, MD, MPH is board certified by the American Board of Internal Medicine in internal medicine and CVD. He has extensive training and expertise in lipidology and echocardiography. He holds additional certifications from the American Board of Clinical Lipidology and the National Board of Echocardiography. Dr. McCullough specializes in treating patients with complicated internal medicine problems that have affected important organs including the heart and kidneys.

Dr. McCullough oversees cardiology training, education and research for the Baylor Health Care System and is Vice Chief of Medicine at Baylor University Medical Center at Dallas. He is an internationally recognized authority in his field and frequently lectures on internal medicine, nephrology and cardiology. In addition, he has published over a thousand related scientific communications. He is currently serving as the chair of the National Kidney Foundation’s Kidney Early Evaluation Program, the largest community screening effort for chronic diseases in America.

Dr. Peter A. McCullough, MD

George Bakris, MD, specializes in the diagnosis and reduction of high blood pressure, particularly in complicated and refractory cases. He is also skilled in the treatment of kidney disease, with special expertise in diabetes-related kidney disease and slowing its progression.

In his research activities, Dr. Bakris explores why the rate of kidney disease is significantly higher in the black population than it is in other ethnic groups. He also evaluates specific markers of kidney disease progression and heightened cardiovascular risk, as well as how changes in the artery (central pressure) affect the heart and kidney. He has served on many guidelines’ committees over the past 15 years and is currently the chair of the ADA High Blood Pressure Consensus Panel and Clinical Practice Guideline Committee. He is also a member of the AHA panel updating resistant hypertension guidelines.

Dr. Bakris received the Irvine Page-Alva Bradley Lifetime Achievement Award to acknowledge his lifetime of outstanding achievements in the field of hypertension

George Bakris, MD Identifying and Managing Renal Complications in Patients with T2D and CVD